ArticleInternational urology and nephrology2026
Association between allostatic load and chronic kidney disease: findings from the NHANES 2015-2018 study.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe allostatic load (AL) is a composite measure of multisystem physiological dysregulation, reflecting the cumulative adverse effects of chronic stress on health outcomes. This study was conducted with the objective of elucidating the association between AL and chronic kidney disease (CKD) by analyzing data derived from a nationally representative cohort of U.S. adults.
methodsWe conducted a cross-sectional analysis based on data from the National Health and Nutrition Examination Survey (NHANES) spaning from 2015 to 2018. The AL was calculated based on laboratory assessments of eight biomarkers-systolic blood pressure (SBP), diastolic blood pressure, body mass index (BMI = weight [kg] divided by height [m
results9,495 participants were incorporated into our analysis. AL was found to be significantly positively associated with CKD in weighted logistic regression analysis (odds ratio = 1.27, 95% confidence interval: 1.22-1.33). Among the eight biomarkers comprising the AL index, HDL cholesterol, SBP, BMI, HbA1c, and Alb were identified as significant predictors of CKD risk in fully adjusted models (P < 0.001). Restricted cubic spline analysis confirmed a positive link between AL and CKD. Subgroup analyses further revealed a significant interaction effect of sex on the AL-CKD relationship.
conclusionThis cross-sectional study elucidates the association between AL and CKD, highlighting the potential influence of demographic factors. Elevated AL were demonstrated to be in close association with increased CKD prevalence, with SBP and HbA1c identified as critical contributors to CKD risk. While these findings enhance comprehension of the link between AL and CKD, additional research is required for further validation.
Indexed as
Identifiers
41572052What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.